General Information of Drug (ID: DMQ2ZTJ)

Drug Name
7-fluorochromone-2-carboxamide Drug Info
Synonyms
CHEMBL214021; 7-fluorochromone-2-carboxamide; GTPL1303; SCHEMBL2669492; BDBM50197139; LS-193885; N-[1-(1,3-benzodioxol-5-ylmethyl)piperidin-4-yl]-7-fluoro-4-oxo-4H-chromene-2-carboxamide; N-[1-(1,3-benzodioxol-5-ylmethyl)piperidin-4-yl]-7-fluoro-4-oxochromene-2-carboxamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
11539096
TTD Drug ID
DMQ2ZTJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-830216 DMCW71N Obesity 5B81 Phase 1 [3]
AZD1979 DMQ1OX4 Obesity 5B81 Phase 1 [4]
PMID25522065-Compound-27 DMXN4KB N. A. N. A. Patented [5]
PMID25522065-Compound-29 DMBNAK9 N. A. N. A. Patented [5]
PMID25522065-Compound-34 DMZDIRQ N. A. N. A. Patented [5]
PMID25522065-Compound-39 DM5YMQH N. A. N. A. Patented [5]
PMID25522065-Compound-40 DMCIQ01 N. A. N. A. Patented [5]
PMID25522065-Compound-11 DM410Z6 N. A. N. A. Patented [5]
PMID25522065-Compound-50 DMBWA0V N. A. N. A. Patented [5]
PMID25522065-Compound-12 DMVKO9C N. A. N. A. Patented [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanin-concentrating hormone receptor 1 (MCHR1) TTX4RTB MCHR1_HUMAN Antagonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1303).
2 Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety. J Med Chem. 2006 Nov 2;49(22):6569-84.
3 2011 Pipeline of Bristol-Myers Squibb.
4 Phase I clinical trial of AZD1979 for treating obesity. AstraZeneca plc
5 Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207.